Publications by authors named "Dennis Brinker"

Claim this Profile
P
Pooled Analysis of Baricitinib Tolerability in Patients With Atopic Dermatitis in Relation to Acne, Headache, and Gastrointestinal Events From 8 Clinical Trials.
Andreas Wollenberg, Leon Kircik, Eric Simpson, Dennis Brinker, Norito Katoh

Dermatitis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).
Thomas Bieber, Kristian Reich, Carle Paul, Yuichiro Tsunemi, Matthias Augustin, Dennis Brinker

Br J Dermatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims Database.
Kristin J Meyers, Jonathan I Silverberg, Maria Jose Rueda, Robert Goodloe, Evangeline J Pierce, Dennis R Brinker

Dermatol Ther (Heidelb)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials.
Brett King, Catherine Maari, Edward Lain, Jonathan I Silverberg, Maher Issa, Dennis Brinker

Am J Clin Dermatol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
Kristian Reich, Kenji Kabashima, Ketty Peris, Jonathan I Silverberg, Lawrence F Eichenfield, Dennis R Brinker

JAMA Dermatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis.
Mark C Genovese, Josef S Smolen, Tsutomu Takeuchi, Gerd Burmester, Dennis Brinker

Lancet Rheumatol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis